Medical Health & Life Science Research News

New report: Monoclonal antibodies market size worth USD 112175.5 million by 2021

Monoclonal Antibodies Market by Source (Murine, Chimeric, Humanized, Human) by Indication (Cancer, Autoimmune diseases, infectious diseases, Cardiovascular diseases, CNS disorders, others) by End-User (Hospitals/Clinics, Research Institute, Diagnostic Laboratories) by Application (Medical, Experimental) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

- Advertising -

According to the report Global Monoclonal Antibodies Market, published by Market Data Forecast, the global market is projected to reach USD 112175.5 million by 2021, at a CAGR of 5.3% from 2016 to 2021.

Monoclonal Antibodies have various diagnostic and therapeutic applications, especially in cancer. Apart from these mAb`s are also useful in protein purification.

At present, there are forty-seven monoclonal antibody products have been approved in the United States or Europe for the treatment of a wide range of diseases, and many of these products have also been approved in the global markets.

- Advertising -

Monoclonal Antibodies, a type of mono-specific antibodies, are comprised of identical antibody molecules and are produced by a single clone of cells or cell line. Monoclonal Antibodies have brought about a fundamental change in pharmaceutical and biotechnology sectors and in the future too are slated to play a crucial role in clinical protocol with further development of these molecular agents.

Monoclonal Antibodies find application in the treatment of a variety of diseases, particularly autoimmune, cancer, and inflammatory diseases.

Get a comprehensive overview of the Global Monoclonal Antibodies Market: http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/

Global Monoclonal Antibodies Market: Drivers & Restraints

Global Monoclonal Antibodies market is driven by increasing R & D activities in genomics, owing to rapid advancements of our understanding of disease at a molecular level. The development of new molecules is expected to play a prominent role in the future of the market due to the cost effectiveness of this technology.

Rising awareness levels among patients and physicians regarding various applications of mAb is also a major factor fuelling the growth of the market. However huge cost and time associated with the identification and development of potential molecules is a major factor hindering the growth of the market

Get accurate market forecast and analysis on the Global Monoclonal Antibodies Market. Request a sample to stay up-to-date on the main trends affecting this market: www.marketdataforecast.com/market-…84/request-sample

Global Monoclonal Antibodies Market: Segmentation

By Source                   

  • Murine    
  • Chimeric 
  • Humanized            
  • Human    

By Indication                             

  • Cancer     

o   Blood Cancer

o   Breast Cancer

o   Colorectal Cancer

o   Lung Cancer

o   Pancreatic Cancer

o   Others

  • Autoimmune Diseases      
  • Infectious Diseases            
  • Cardiovascular Diseases   
  • CNS Disorders      
  • Others (Inflammatory, Microbial Diseases, & Other)            

By End User                    

  • Hospitals/Clinics  
  • Research Institute
  • Diagnostic Laboratories    

By Application                

  • Medical   
  • Experimental        

o   Western Blot

o   ELISA

o   Radioimmune Assays

o   Immunofluorescence

o   Other (Immunohistochemistry, Immunoprecipitation, & Immunocytochemistry)

From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information. Get report at http://www.marketdataforecast.com/market-reports/global-monoclonal-antibodies-market-1184/customize-report

Global Monoclonal Antibodies Market: Overview

The market is showcasing evident potential in the mentioned forecasting period. MAb`s are antibodies produced by a single clone of cells consisting of identical antibody molecules.

Global Monoclonal Antibodies market continues to gain momentum with the rapid increase in adoption of these products for various indications. At the current approval rate of four new products releasing every year, approximately 70 monoclonal antibody products are expected to be present on the market by 2020.

Hospitals is the largest end user segment accounting for a share of approximately XX%. By application global monoclonal antibodies market is segmented into medical and experimental.

Based on experimental the market is further sub segmented into Western Blot, ELISA, Radioimmune Assays, Immunofluorescence and other

Global Monoclonal Antibodies Market: Region-wise Outlook

On the basis of Geography global monoclonal antibodies market is segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the largest market for monoclonal antibodies accounting for a share of approximately XX% followed by Europe.

Asia-Pacific region is estimated to be the fastest growing with a CAGR of XX% during the forecast period owing to huge population base.

Key Questions Answered

  • What is the current and future Global Monoclonal Antibodies Market outlook in global? What trends are affecting the global market?
  • What is the competitive landscape and market share of major players in the Global Monoclonal Antibodies space globally?
  • What are the key, high growth markets that Global Monoclonal Antibodies manufacturers should expand into? Which market segments are growing the fastest?
  • What are the unmet needs with the Global Monoclonal Antibodies currently on the market? How will emerging technologies fulfil these unmet needs?
  • What is physician perception and market outlook of Global Monoclonal Antibodies?
  • What are the challenges and barriers that have hindered widespread adoption of Global Monoclonal Antibodies?

Global Monoclonal Antibodies Market: Key Players

Some of the major companies dominating the market, by their products include GlaxoSmithKline plc (U.K.), Novartis AG (Switzerland), Pfizer Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Eli Lilly and Company (U.S.), Seattle Genetics (U.S.), Bristol-Myers Squibb (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Teva Pharmaceutical Industries Ltd. (Israel) and Shanghai Junshi Bioscience Co.,Ltd. (China).

Reasons to access Global Monoclonal Antibodies Market Report:

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
  • Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porter’s Five Forces Analyses
  • A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

News From

Market Data Forecast - market research, business intelligence and consultingMarket Data Forecast
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...